Ownership and insider activity for Nuwellis, Inc. (NUWE): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc.
Price
| Price | $0.81 |
| Market Cap | $0M |
| Exchange | NASDAQ |
| Country | US |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.3M | $15.6M | $5.5M | $1.3M | $14.4M | $8.7M | $17.7M | $3.8M | $5.1M | $1.1M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | $15.5M | $569000 | 0 | 0 | 0 |
| Receivables | $282000 | $545000 | $786000 | $799000 | $905000 | $750000 | $1.4M | $2.0M | $1.7M | $1.5M |
| Inventory | $677000 | $1.6M | $1.7M | $1.8M | $3.0M | $2.8M | $2.7M | $2.0M | $1.7M | $1.9M |
| Total Current Assets | $2.4M | $17.9M | $8.1M | $4.0M | $18.5M | $28.1M | $22.8M | $8.2M | $8.9M | $5.2M |
| Property, Plant & Equipment | $540000 | $570000 | $536000 | $1.4M | $1.5M | $2.3M | $1.9M | $1.4M | $988000 | $661000 |
| Goodwill | $99000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $4.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | $7.5M | $18.5M | $8.8M | $5.6M | $20.0M | $30.4M | $24.7M | $9.8M | $9.9M | $6.1M |
| Accounts Payable | $2.0M | $862000 | $1.1M | $1.5M | $1.1M | $1.4M | $2.2M | $2.4M | $1.6M | $2.0M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $216000 | 0 | $261000 |
| Total Current Liabilities | $3.3M | $2.1M | $2.8M | $3.4M | $3.6M | $3.3M | $4.7M | $3.2M | $2.6M | $3.0M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $5.7M | $2.2M | $2.8M | $3.6M | $3.7M | $4.5M | $12.3M | $6.6M | $3.3M | $3.5M |
| Retained Earnings | -$169.0M | -$182.4M | -$199.4M | -$217.5M | -$233.3M | -$252.9M | -$267.4M | -$287.6M | -$298.8M | -$316.3M |
| Total Equity | $1.8M | $16.2M | $5.9M | $2.0M | $16.3M | $25.9M | $12.4M | $3.2M | $6.5M | $2.6M |
| Total Debt | 0 | 0 | 0 | $447000 | $339000 | $1.2M | $984000 | $760000 | $545000 | $328000 |
| Net Debt | -$1.3M | -$15.6M | -$5.5M | -$832000 | -$14.1M | -$23.0M | -$17.3M | -$3.0M | -$4.5M | -$757000 |
| Working Capital | -$841000 | $15.8M | $5.3M | $684999 | $15.0M | $24.8M | $18.1M | $5.0M | $6.3M | $2.2M |
Financial Health
| Debt / Equity | -0.10 |
| Current Ratio | 1.97 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -74.53 |
Profitability
| Return on Equity | -605.75% |
| Return on Invested Capital | -238.32% |
| Return on Assets | -121.85% |
| Gross Margin | 69.69% |
| Operating Margin | -140.62% |
| Net Margin | -123.38% |
Related companies: ACON · BACK · BCTXW · IVF · NUVO · OCEA · PETV
Explore sector: Healthcare · Medical - Devices
More sections of NUWE: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks